The US approval of perpetual futures contracts may lead to unforeseen tax and regulatory issues for traders if these products are ultimately deemed to be swaps rather than futures, according to CME Group Chairman and CEO Terry Duffy. In an interview, Duffy emphasized the ambiguity surrounding the tax treatment of perpetual futures, stating that 'there's a consequence that nobody's talking about' and that 'there's ambiguity right there, from a tax perspective, for all US participants now.' The comments come amid CME's ongoing legal challenge against the Commodity Futures Trading Commission (CFTC) over the regulator's approval of perpetual futures contracts in the US. The dispute centers on whether perpetual futures should be legally classified as futures or swaps, with Duffy arguing that they should be considered swaps due to the periodic funding payments exchanged between long and short positions.
This classification could significantly impact how the Internal Revenue Service (IRS) taxes these contracts, as institutional traders may be subject to 'ordinary' taxation rather than the blended tax treatment available under Section 1256 of the US tax code. However, legal experts note that the issue is complex and that the definition of swaps is extremely broad, leaving room for interpretation.
The outcome of the court decision could have far-reaching consequences for market participants, with Duffy warning that traders who have been treating perpetual futures as futures for tax purposes may face uncertainty about how to report those positions to the IRS. Ultimately, the classification of perpetual futures as swaps or futures will depend on the court's interpretation, and tax authorities may need to provide separate guidance on the tax treatment of these contracts.